Integer (NYSE:ITGR) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Integer (NYSE:ITGR) from a hold rating to a buy rating in a research note issued to investors on Saturday.

ITGR has been the topic of a number of other reports. Argus downgraded Integer from a “buy” rating to a “hold” rating in a research report on Friday, October 24th. KeyCorp decreased their target price on Integer from $145.00 to $133.00 and set an “overweight” rating for the company in a research report on Tuesday, October 21st. Wells Fargo & Company restated an “equal weight” rating and set a $80.00 target price (down from $132.00) on shares of Integer in a research report on Friday, October 24th. Bank of America downgraded Integer from a “buy” rating to a “neutral” rating and set a $87.00 price objective on the stock. in a research report on Friday, October 24th. Finally, Truist Financial increased their target price on Integer from $86.00 to $95.00 and gave the stock a “buy” rating in a research report on Thursday, December 18th. Four research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $98.38.

Integer Trading Up 0.6%

Shares of NYSE ITGR opened at $85.78 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.45 and a current ratio of 3.71. Integer has a 52-week low of $62.00 and a 52-week high of $146.36. The company has a market cap of $3.01 billion, a PE ratio of 35.89, a P/E/G ratio of 0.79 and a beta of 0.78. The firm’s 50 day moving average price is $75.30 and its 200-day moving average price is $92.62.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.During the same quarter in the prior year, the firm earned $1.43 earnings per share. The business’s quarterly revenue was up 8.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. On average, equities research analysts expect that Integer will post 6.01 EPS for the current fiscal year.

Integer announced that its Board of Directors has approved a share buyback plan on Tuesday, November 4th that permits the company to repurchase $200.00 million in outstanding shares. This repurchase authorization permits the medical equipment provider to repurchase up to 8.3% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s management believes its stock is undervalued.

Insider Buying and Selling

In other news, Director Cheryl C. Capps purchased 1,600 shares of the company’s stock in a transaction on Thursday, November 6th. The stock was bought at an average cost of $66.70 per share, for a total transaction of $106,720.00. Following the completion of the purchase, the director directly owned 11,702 shares of the company’s stock, valued at $780,523.40. The trade was a 15.84% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Tommy P. Thomas sold 884 shares of the firm’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $70.15, for a total value of $62,012.60. Following the sale, the vice president owned 3,596 shares of the company’s stock, valued at approximately $252,259.40. This trade represents a 19.73% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders bought 5,843 shares of company stock worth $384,771. Corporate insiders own 2.16% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Integer by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock valued at $2,539,000 after acquiring an additional 837 shares during the period. Millennium Management LLC lifted its holdings in Integer by 2,408.8% in the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after purchasing an additional 118,224 shares during the last quarter. Jones Financial Companies Lllp raised its holdings in Integer by 79,888.9% in the 1st quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock worth $850,000 after acquiring an additional 7,190 shares during the period. United Services Automobile Association bought a new position in shares of Integer in the first quarter worth about $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Integer by 4.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock worth $12,900,000 after buying an additional 4,873 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.